Cerebrovascular accident

Disease1 paper

Humans1

Trial sponsors

Viatris
Company3 trialsPhase 42,803 people
Pfizer
Company2 trialsPhase 411,400 people
Axio Research
Company1 trialPhase 33,414 people
Boehringer Ingelheim
Company1 trialPhase 31,295 people
Department of Psychiatry, University of Pittsburgh
1 trialPhase 440 people
University of British Columbia
1 trialPhase 33,020 people
Massachusetts General Hospital
1 trialPhase 3
Joyce Chen
1 trialPhase 2/31,164 people

Latest

7

European Heart Journal OpenHumans15 Sep

Determinants and prognostic value of atrial and ventricular ectopic burden in adults without structural heart disease

Research SquareHumansPreprint1 Sep

Frailty Assessed by the Edmonton Frail Scale in Maintenance Haemodialysis: A Multicentre Cross-Sectional Study

AHA Scientific Sessions 2025 AbstractHumans3 Nov

Long-Term Impact of GLP-1 Receptor Agonists on Cardiovascular Outcomes in Patients Treated with Hematopoietic Stem Cell Transplantation: A Propensity-Score Matched Analysis

AHA Scientific Sessions 2025 AbstractHumans3 Nov

Comparative Effects of Tirzepatide vs Semaglutide on 1-Year Mortality and Cardiovascular Outcomes in T2DM Patients with HFpEF

AHA Scientific Sessions 2025 AbstractHumans3 Nov

Trends and Disparities in Cerebrovascular Disease and Chronic Kidney Disease-Related Mortality in the United States, 1999–2019: A Nationwide Analysis

AHA Scientific Sessions 2025 AbstractHumans3 Nov

Five-Year Outcomes of Glucagon-Like Peptide-1 Agonists in Obstructive Hypertrophic Cardiomyopathy: A Population-Based Retrospective Study

AHA Scientific Sessions 2025 AbstractHumans3 Nov

Assessment of Lipid-Lowering Therapy and Atherosclerotic Cardiovascular Disease Outcomes in Patients with Familial Hypercholesterolemia: Insights from the NIH All Of Us Dataset

ADA Scientific Sessions 2025 AbstractHumans13 Jun

Handgrip Strength and Glucose Metabolism on the Risk of Cerebrovascular Accidents and All-Cause Mortality